Global Industrial Microbiology Sales are Surging at 4.95% CAGR amid Expansion of Biopharmaceutical Industry and Increasing Adoption of Sterility Testing - Future Market Insights
Comunicato Precedente
Comunicato Successivo
Increasing demand for safety and hygiene in food industry will encourage improvement in the quality of products. Driven by this, the focus on quality of products across diverse industries has encouraged manufacturers to emphasize on the adoption of sterility and safety testing to ascertain product quality. This is expected to bolster industrial microbiology sales growth in coming years.
Spurred by consistently rising demand, several leading players are focusing on product launches. For instance, in 2018, BioMerieuxx,a leading player in industrial microbiological control field has launched ENDOZYME® II GO, a new endotoxin test in the BioMerieuxx ENDONEXT™ range of recombinant horseshoe crab Factor C assays.
Focus on drug development and increasing demand for pathogen testing in food products also creating opportunities for sales.
According to the Association of British Pharmaceutical Industry (ABPI), investment in research and development activities targeted at enhancing industrial microbiology products have resulted in expenditure on healthcare to increase.
As per ABPI, the pharmaceutical sector investment totaled US$ 156.7 Bn in 2016 and it is estimated to increase in coming years, creating impressive scope for the growth of the market.
Stringent regulations implemented on the use of the anti-microbial food additives and favorable policies are supporting adoption of sterility testing. This in turn, accelerating demand for industrial microbiology.
For instance, in 2020, the U.S. Food and Drug Administration for pharmaceutical microbiology and the U.S. government made it compulsory for industries to undergo sterility testing and bio-burden testing to examine toxicity level of a drug or additives. Implementation of stringent regulations such as this will create opportunities for growth of the market.
Request a report sample to gain comprehensive insights at ttps://www.futuremarketinsights.com/reports/sample/rep-gb-1743
"Rising usage of microorganisms in syrup formulations has improved adoption of sterility and bio-burden testing. Growing demand for pathogen testing in the food sector and increasing drug development are creating opportunities for market growth," said a Future Market Insights (FMI) analyst.
Key Takeaways from Industrial Microbiology Market:
Growth Drivers:
Our advisory services are aimed at helping you with specific, customized insights that are relevant to your specific challenges. Let us know about your challenges and our trusted advisors will connect with you: https://www.futuremarketinsights.com/ask-question/rep-gb-1743
Competitive Landscape
Key players operating in the global industrial microbiology market are focusing on expanding their businesses and their overall market share. For instance,
In 219, Aberdeen-based microbiology, and biological material storage company NCIMB Ltd collaborated with German distributor Doenitz Prolab to expand their consumer base and to provide microbiology products and services.
Key players operating in the global industrial microbiology market include:
More Insights on the Global Industrial Microbiology Market
Fact MR provides an unbiased analysis of the global industrial microbiology market, presenting historical demand data (2016-2020) and forecast statistics for the period from 2021-2031. The study divulges compelling insights on the global sales of industrial microbiology market with a detailed segmentation on the basis of:
Product Type:
By End User:
By Test Type:
By Region:
Contact Sales for Further Assistance in Purchasing this Report@ https://www.futuremarketinsights.com/checkout/1743
Key Questions Covered in the Industrial Microbiology Market Report
Explore FMI's Extensive Coverage on Healthcare Domain
Pharmacovigilance Market: Pharmacovigilance Solutions for Stage IV Trials to Generate over Three-Quarters of Market Demand.
Advanced Wound Management Market: Rising Cases of Chronic Ulcers to Spur Sales in Advanced Wound Management Market: FMI
High Content Screening Market: High Content Screening Market to Surpass US$ 1.5 Bn by 2021, Driven by Increasing Drug Discovery and Cell Biology Research
About Future Market Insights (FMI):
Future Market Insights (FMI) is a leading provider of market intelligence and consulting services, serving clients in over 150 countries. FMI is headquartered in Dubai, and has delivery centers in the UK, U.S. and India. FMI's latest market research reports and industry analysis help businesses navigate challenges and make critical decisions with confidence and clarity amidst breakneck competition. Our customized and syndicated market research reports deliver actionable insights that drive sustainable growth. A team of expert-led analysts at FMI continuously tracks emerging trends and events in a broad range of industries to ensure that our clients prepare for the evolving needs of their consumers.
Contact:
Abhishek Budholiya
Future Market Insights,
1602-6 Jumeirah Bay X2 Tower,
Plot No: JLT-PH2-X2A,
Jumeirah Lakes Towers, Dubai,
United Arab Emirates
For Sales Enquiries: [email protected]
For Media Enquiries: [email protected]
Website: https://www.futuremarketinsights.com/
Report: https://www.futuremarketinsights.com/reports/industrial-microbiology-market
Press Release Source: https://www.futuremarketinsights.com/press-release/industrial-microbiology-market
Logo: https://mma.prnewswire.com/media/1197648/FMI_Logo.jpg
Ufficio Stampa
PR Newswire (Leggi tutti i comunicati)
209 - 215 Blackfriars Road
LONDON United Kingdom




